Mod GRF 1-29 vs Pinealon

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Mod GRF 1-29

Mod GRF 1-29 (Modified GRF 1-29, also called CJC-1295 without DAC or Tetrasubstituted GRF 1-29) is a modified growth hormone-releasing hormone analog with improved stability over natural GHRH.

Full details →

Pinealon

Pinealon is a short synthetic peptide developed from research on the pineal gland. It has shown neuroprotective and cognitive-enhancing properties in animal studies.

Full details →

Side-by-Side Comparison

Aspect	Mod GRF 1-29	Pinealon
Dose Range	100 mcg–200 mcg	5 mg–10 mg
Frequency	3x daily	1x daily
Cycle Length	8–12 weeks	1–2 weeks
Route	subcutaneous	subcutaneous
Mechanism	Binds to GHRH receptors in the pituitary gland to stimulate growth hormone release. Four amino acid substitutions improve resistance to enzymatic degradation while maintaining biological activity.	Penetrates cell membranes and interacts with DNA to regulate gene expression related to neuronal survival and function. May support pineal gland function and melatonin production.
Typical Dosage	Typical dosing: 100-300mcg administered 2-3 times daily, usually combined with a GHRP like Ipamorelin for synergistic effects.	Typical dosing: 10-20mg daily, taken in divided doses. Often used in cycles of 10-20 days.
Administration	Subcutaneous injection. Best administered on empty stomach. Short half-life (~30 minutes) necessitates multiple daily doses, unlike DAC version.	Can be taken orally (capsules) or sublingually. Best absorbed on an empty stomach. Often combined with other neuroprotective peptides.
Side Effects	Flushing, headache, dizziness, and injection site reactions. Generally well-tolerated. May cause water retention.	Generally well-tolerated. Limited reported side effects. May affect sleep patterns initially.
Best For	Muscle Growth Fat Loss Recovery & Healing Sleep Quality	Sleep Quality Cognitive Performance